TOVX (Theriva Biologics) Buyback Yield %: -145.02 (As of Jul. 09, 2026)


TOVX Theriva Biologics Inc TOVX
26 GF Score
Price $0.23
! 3 Warning Signs
View Full Analysis

What is Theriva Biologics Buyback Yield %?

Theriva Biologics TOVX -1.39% 26 Buyback Yield % is -145.02 as of Jul. 09, 2026. GuruFocus rates TOVX with a GF Score™ of 26/100. The stock has 3 warning signs investors should review. Among 741 Biotechnology companies, Theriva Biologics ranks worse than 92.98% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Theriva Biologics's current buyback yield was -145.02%.

Theriva Biologics Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Theriva Biologics's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theriva Biologics Buyback Yield % Chart

Theriva Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -183.58 4.19 -30.08 -114.27 -180.10

Theriva Biologics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -170.24 -166.94 -180.10 -176.12

TOVX vs OSRH, PBM, PHIO: Buyback Yield % Comparison

For the Biotechnology subindustry, Theriva Biologics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Theriva Biologics Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Theriva Biologics's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Theriva Biologics's Buyback Yield % falls into.


TOVX
26GF Score
Theriva Biologics Inc TOVX
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Theriva Biologics Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Theriva Biologics's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 13.523) / 7.5087552
=-180.10%

Theriva Biologics's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 15.826) / 8.9858494
=-176.12%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -145.02 mean?
Theriva Biologics (TOVX) has a Buyback Yield % of -145.02 as of Jul. 09, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Theriva Biologics and its competitors. According to the industry distribution chart, Theriva Biologics ranks #689 out of 741 companies in the Biotechnology industry, placing it in the top 93%.
Is Theriva Biologics' Buyback Yield % too high?
Theriva Biologics' current Buyback Yield % is -145.02. Based on the distribution chart, Theriva Biologics ranks #689 out of 741 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Theriva Biologics has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Theriva Biologics' Buyback Yield % compare to OSRH and PBM?
According to the Biotechnology industry distribution chart, Theriva Biologics ranks #689 out of 741 companies for Buyback Yield %. This places Theriva Biologics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Theriva Biologics and its competitors. Theriva Biologics's current Buyback Yield % is -145.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Theriva Biologics stock overvalued right now?
Theriva Biologics (TOVX) has a current Buyback Yield % of -145.02. The current Buyback Yield % is -145.02. Theriva Biologics' overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Theriva Biologics (TOVX), the current Buyback Yield % is -145.02 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Theriva Biologics Business Description

Address 9605 Medical Center Drive, Suite 270, Rockville, MD, USA, 20850
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.
26GF Score

Get the complete analysis for TOVX

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.23
Price